Amex Exploration (CVE:AMX) Trading 4% Higher - Should You Buy?

Key Points

• Shares of Amex Exploration Inc. (CVE:AMX) increased by 4%, trading at C$2.87, with a notable surge in trading volume, up 80% from average levels.
• Haywood Securities has upgraded their target price for Amex Exploration from C$3.00 to C$4.00, reflecting strong market interest with an average rating of “Strong Buy”.
• The company focuses on gold mining exploration in Canada, holding interests in several projects, including the Perron and Lebel-sur-Quévillon projects in Quebec.

Shares of Amex Exploration Inc. (CVE:AMX - Get Free Report) traded up 4% during trading on Monday . The company traded as high as C$2.87 and last traded at C$2.87. 303,028 shares changed hands during trading, an increase of 80% from the average session volume of 167,885 shares. The stock had previously closed at C$2.76.

Analyst Upgrades and Downgrades

Separately, Haywood Securities increased their target price on Amex Exploration from C$3.00 to C$4.00 in a report on Monday, September 8th. One analyst has rated the stock with a Strong Buy rating and one has assigned a Buy rating to the company. Based on data from MarketBeat.com, Amex Exploration has an average rating of "Strong Buy" and an average target price of C$3.00.

Amex Exploration Stock Performance

The stock's 50-day moving average is C$2.24 and its 200 day moving average is C$1.59. The stock has a market capitalization of C$406.17 million, a PE ratio of -114.80 and a beta of 2.21.

Amex Exploration Company Profile

Amex Exploration Inc, together with its subsidiaries, engages in the exploration of gold mining properties in Canada. The company holds interest in the Perron project and the Lebel-sur-Quévillon project located in Quebec. It also holds interest in the Eastmain River South, North, and Central projects located in Chibougamau, Quebec.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.